These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25951953)
21. A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial. O'Neil MM; Johnson RA; Córdova D; Pryor J; Pinals DA BMC Public Health; 2023 Mar; 23(1):435. PubMed ID: 36879259 [TBL] [Abstract][Full Text] [Related]
22. Delivery of the HIV Service and Telemedicine Through Effective Patient-Reported Outcomes (+STEP) Intervention to Increase Screening and Treatment of Mental Health and Substance Use Disorders for People Living With HIV in Alabama: Protocol for an Effectiveness-Implementation Study. Gagnon KW; Baral S; Long D; Guzman AL; Johnson B; Burkholder G; Willig J; Mugavero M; Baldwin M; Fogger S; Creger T; Cropsey K; Eaton E JMIR Res Protoc; 2023 Aug; 12():e40470. PubMed ID: 37581919 [TBL] [Abstract][Full Text] [Related]
23. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers. Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408 [TBL] [Abstract][Full Text] [Related]
24. Patient predictors of substance use disorder treatment initiation in primary care. Ober AJ; Watkins KE; McCullough CM; Setodji CM; Osilla K; Hunter SB J Subst Abuse Treat; 2018 Jul; 90():64-72. PubMed ID: 29866385 [TBL] [Abstract][Full Text] [Related]
25. Testing the leadership and organizational change for implementation (LOCI) intervention in substance abuse treatment: a cluster randomized trial study protocol. Aarons GA; Ehrhart MG; Moullin JC; Torres EM; Green AE Implement Sci; 2017 Mar; 12(1):29. PubMed ID: 28253900 [TBL] [Abstract][Full Text] [Related]
26. Using NIATx strategies to implement integrated services in routine care: a study protocol. Ford JH; Osborne EL; Assefa MT; McIlvaine AM; King AM; Campbell K; McGovern MP BMC Health Serv Res; 2018 Jun; 18(1):431. PubMed ID: 29884164 [TBL] [Abstract][Full Text] [Related]
27. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study. Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness of a multi-level implementation strategy for ASD interventions: study protocol for two linked cluster randomized trials. Brookman-Frazee L; Stahmer AC Implement Sci; 2018 May; 13(1):66. PubMed ID: 29743090 [TBL] [Abstract][Full Text] [Related]
29. Health facility readiness to screen, diagnose and manage substance use disorders in Mbale district, Uganda. Aber-Odonga H; Nuwaha F; Kisaakye E; Engebretsen IMS; Babirye JN Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):63. PubMed ID: 37925411 [TBL] [Abstract][Full Text] [Related]
30. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
33. Optimizing a community-engaged multi-level group intervention to reduce substance use: an application of the multiphase optimization strategy. Windsor LC; Benoit E; Smith D; Pinto RM; Kugler KC; Trials; 2018 Apr; 19(1):255. PubMed ID: 29703237 [TBL] [Abstract][Full Text] [Related]
34. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial. Frimpong JA; D'Aunno T; Perlman DC; Strauss SM; Mallow A; Hernandez D; Schackman BR; Feaster DJ; Metsch LR Trials; 2016 Mar; 17(1):117. PubMed ID: 26936623 [TBL] [Abstract][Full Text] [Related]
35. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162 [TBL] [Abstract][Full Text] [Related]
36. Validation of the Implementation Climate Scale (ICS) in substance use disorder treatment organizations. Ehrhart MG; Torres EM; Hwang J; Sklar M; Aarons GA Subst Abuse Treat Prev Policy; 2019 Aug; 14(1):35. PubMed ID: 31443666 [TBL] [Abstract][Full Text] [Related]
37. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. Satre DD; Palzes VA; Young-Wolff KC; Parthasarathy S; Weisner C; Guydish J; Campbell CI J Subst Abuse Treat; 2020 Nov; 118():108097. PubMed ID: 32972648 [TBL] [Abstract][Full Text] [Related]
38. Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial. Van Dorn RA; Desmarais SL; Rade CB; Burris EN; Cuddeback GS; Johnson KL; Tueller SJ; Comfort ML; Mueser KT Trials; 2017 Aug; 18(1):365. PubMed ID: 28778175 [TBL] [Abstract][Full Text] [Related]